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Introduction
Laparoscopic cholecystectomy (LC) is currently accepted as the reference standard for the management of symptomatic or complicated gallstone disease. There is now increasing evidence to support ambulatory LC as the standard of care as a result of its ability to improve patient recovery and significantly reduce hospital stay. [1] [2] [3] [4] Laparoscopic cholecystectomy would appear to be an ideal operation for ambulatory surgery because it is of short duration, uses small incisions, carries a low rate of immediate complications and does not disrupt gastrointestinal homeostasis. Despite this, several series describing ambulatory LC have reported inpatient admission rates of up to 20%, mainly for nausea, vomiting or uncontrolled pain.
5-7
The aim of this study was to develop an evidence-based approach to ambulatory LC by systematically reviewing all published randomized controlled trials (RCTs) of pre-, intra-and postoperative interventions aimed at improving postoperative pain, postoperative nausea and vomiting (PONV), patient satisfaction and general well-being following LC.
Materials and methods

Search strategy
The search sought to identify published RCTs analysing the efficacy of preoperative (initiated prior to anaesthetic room), intraoperative (initiated in the anaesthetic or operating room) and postoperative (initiated in recovery or beyond) interventions during LC that can optimize early discharge and enhance patient recovery.
A search of the PubMed and CENTRAL (Cochrane Central Register of Controlled Trials) databases for materials published from 1990 to December 2009 was performed using the following key MeSH terms: cholecystectomy; laparoscopic/; laparoscopic cholecystectomy.mp; ambulatory surgical procedures/; anaesthesia/; preoperative care/; postoperative care/; intraoperative care/; patient education as topic/ OR patient education.mp, and drainage/ OR drainage.mp. The search was limited to studies published in the English language, studies in humans and RCTs.
Eligibility criteria
This search was based on two hypotheses: firstly, that ambulatory LC would prove to be feasible, safe and effective, and, secondly, that pain, PONV and other postoperative complications resulting in low levels of patient satisfaction would emerge as barriers to ambulatory LC. Publications debating the above hypotheses were excluded. Other exclusion criteria were: (i) a focus on comparisons of patient characteristics as predictors of success in ambulatory LC; (ii) indistinguishable or mixed-participant populations of LC patients with other surgical patients; (iii) primary outcome measures other than postoperative pain, PONV, patient satisfaction, time to discharge or other determinants of discharge of patients postoperatively; (iv) publication in languages other than English; (v) non-human participants; (vi) non-RCT formats, and (vii) studies with a Jadad score 8 of <3.
Study selection
Initial selection Potential articles were identified by the search strategy described above. Their titles and abstracts were manually screened by the primary reviewer and the eligibility criteria were applied. Any contentious issues were then resolved by the consensus of all authors. Duplicate studies and studies that did not meet eligibility criteria were then excluded.
Data extraction
Eligible manuscripts were analysed according to data extraction completed as described in the Appendix and allocated a Jadad score. 8 Publications with a Jadad score of <3 were subsequently excluded from review.
9-11 Consensus on Jadad scores was achieved by at least two authors.
A summary statement for each intervention was constructed on the calculated strength of evidence 12,13 (Table 1) and grade of recommendation [12] [13] [14] [15] (Table 2) .
Results
The search yielded 331 potential articles; 263 articles were excluded from the analysis as they did not meet the inclusion criteria ( Fig. 1) . Of the 68 manuscripts included for analysis, 28 (41%) had a Jadad score of 3, 23 (34%) had a score of 4, and 17 (25%) had a score of 5.
Preoperative interventions
Correction of preoperative dehydration is likely to be beneficial (Level IB) Two well-conducted studies 6,16 assessed the effect of preoperative carbohydrate (CHO) drinks with divergent conclusions. Importantly, the two trials differed in their anaesthesia protocols. In the trial in which significant improvements in postoperative parameters were measured, 6 patients received an increased volume of intraoperative i.v. fluid compared with patients in the trial in which no significant difference was observed. Hence the routine use of preoperative CHO drinks cannot currently be recommended and further studies are indicated. In an effort to assess the effect of preoperative dehydration, Adanir et al. 5 performed a double-blind RCT (n = 210) comparing pre-and intraoperative i.v. fluid replacement for an assumed fluid deficit caused by an overnight fast. This well-powered study showed that PONV was significantly reduced in those receiving preoperative rehydration (48%) compared with those receiving intraoperative replacement alone (64%).
Dexamethasone 8 mg i.v. should be given preoperatively (Level IA) Seven randomized trials 17-23 assessed the effect of dexamethasone on PONV. All seven trials used 8 mg of i.v. dexamethasone as the standard dose, although the timing of dexamethasone administration varied from as early as 90 min preoperatively to as late as induction of anaesthesia. The incidence of PONV ranged from 58% to 75% in the placebo groups and from 20% to 35% in the dexamethasone groups. In two trials, 20,21 dexamethasone was given in addition to a serotonin receptor antagonist, resulting in a 3-5% incidence of PONV, compared with a 17-18% incidence in the group receiving a serotonin antagonist alone. Interestingly, two of the placebo-controlled trials 20,23 showed a significant reduction in postoperative pain scores with the administration of an anti-emetic. In both trials, dexamethasone was administered 90 min prior to surgery, whereas in the two placebo-controlled trials, 17, 22 in which no reduction in postoperative pain scores was observed with dexamethasone, it was administered at anaesthetic induction. Favourable outcomes appear to be limited to dexamethasone as an equipotent dose of oral prednisone (50 mg) showed no significant difference in outcomes measured. 33 administered clonidine 150 mcg orally 60-90 min prior to anaesthetic induction and showed that patients in the clonidine group required less analgesia in the first 24 h postoperatively compared with those in the placebo group. Similarly, the analgesic efficacy of a g-aminobutyric acid analogue, pregabalin, significantly reduced postoperative pain in a single trial. 34 Five trials 35-39 described outcomes in patients receiving multimodal analgesia. They used a variety of analgesic combinations which included NSAIDs, COX II inhibitors, oxycodone, gabapentin, local anaesthetic and intrathecal morphine and thus are not directly comparable. However, four of these trials 36-39 showed a significant reduction in postoperative pain without a reduction in PONV. In a trial reported by Gilron et al., 39 no reduction in postoperative pain scores was seen in patients receiving a multimodal approach compared with those receiving a single agent alone.
Intraoperative interventions
A liberal intraoperative fluid regimen is superior to a restrictive approach (Level IB) Holte et al. 40 conducted a double-blind RCT of 48 patients undergoing elective LC. The aim of the study was to compare two different intraoperative i.v. fluid regimens of, respectively, a liberal (40 ml/kg) and a restrictive (15 ml/kg) administration of lactated Ringer's solution. The results overwhelmingly favoured the liberal intraoperative fluid regimen, in which all physiological subjective recovery measures and clinical outcomes were significantly improved. Although the study was underpowered, hospital stay in the liberal i.v. fluid group was significantly shorter than that in the restricted-fluid group [i.e. of the patients eligible for same-day discharge, 21 of 22 patients in the liberal i.v. fluid group were discharged compared with only 15 of 23 in the restricted-fluid group (P = 0.02)]. It should be noted that this trial applied significant exclusion criteria which excluded half the patients in the liberal i.v. fluid arm from analysis for reasons of significant cardiovascular comorbidity.
Intraoperative magnesium or esmolol infusion may be useful in reducing postoperative pain (Level IB) One trial examined the effect of an intraoperative magnesium infusion on postoperative pain following LC. Mentes et al. 41 randomized 83 patients to receive either a 50-mg/kg infusion of magnesium sulphate (MgSO4) or placebo. The treatment group showed significant reductions in postoperative pain scores and significantly reduced patient-controlled analgesia use. A further trial assessed the effect of an esmolol infusion and found that it reduced PONV, decreased postoperative pain and led to earlier discharge. 42 Pneumoperitoneal pressure of Յ9 mmHg may be useful in reducing postoperative pain scores (Level IB) Five trials [43] [44] [45] [46] [47] assessed the effect of pneumoperitoneum on postoperative pain. Low-pressure pneumoperitoneum was defined as pressure of 7-9 mmHg and standard pressure as pressure of 12-13 mmHg. Although three trials [44] [45] [46] showed reduced pain scores with low-pressure pneumoperitoneum, two trials did not. These included a well-powered study 43 and a further trial performed in patients undergoing ambulatory cholecystectomy. 45 Pre-incisional local anaesthesia to wounds and peritoneum should be used (Level IA) Thirteen trials [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] examined the use of local anaesthesia (LA) during LC. Intraperitoneal LA was shown to be beneficial in seven of nine trials. [48] [49] [50] [51] [52] [53] [54] 57 In two trials, 49, 50 in which no difference emerged, LA was administered at the end of the procedure. Karaaslan et al. 54 showed the effect of LA to be greatest when it was administered at the commencement of pneumoperitoneum. Alkhamesi et al. 51 showed aerosolized LA to be more effective than injected intraperitoneal LA. Eight trials 51, 53, [55] [56] [57] [58] [59] [60] examined the effect of incisional LA, including two 53, 57 which combined this with intraperitoneal LA. Of these trials, only two did not show a significant benefit with incisional LA and one 51 of these administered it postoperatively. Pre-incisional LA has been shown to be superior to post-incisional infiltration. 58 Although Ure et al. 59 concluded no effect from pre-incisional LA, they reported a significant increase in the number of pain-free patients in the postoperative period. Two trials 53, 57 showed that the combination of intraperitoneal and incisional LA is superior to either method alone and reduces PONV. 57 Intra-abdominal drains should not be used routinely (Level IA) Three trials examined the effect of placing an intra-abdominal drain. Two of these trials 1,61 placed sub-hepatic drains. Both were well powered and showed a significant increase in postoperative pain using a visual analogue scale (VAS) in patients in whom sub-hepatic drains were placed compared with controls. In the third trial, Nursal et al. 62 placed sub-diaphragmatic drains with the aim of removing residual gas following pneumoperitoneum. No differences in use of postoperative analgesia or anti-emetics were observed.
Other intraoperative interventions
Other intraoperative interventions aimed at reducing postoperative pain included two trials 63, 64 assessing the effect of ketamine. Neither trial showed any clinically significant improvement in postoperative pain. Boccara et al. 65 found that ketoprofen given just prior to induction was superior to both ketoprofen given at the end of the procedure or propacetamol, further supporting the use of preoperative NSAIDs. Cekmen et al. 66 studied the efficacy of transcutaneous electrical nerve stimulation (TENS) on PONV and found it to be effective in reducing PONV and decreasing the need for analgesia and anti-emetics (Level IIB).
Anti-emetics significantly reduce PONV (Level IA). Serotonin antagonists droperidol, metoclopramide, gabapentin and dixyrazine are all effective in reducing PONV (Level IB). Total i.v. anaesthesia combined with anti-emetics significantly reduces PONV compared with either alone (Level IB) Two trials compared volatile anaesthesia with total i.v. anaesthesia (TIVA). 67, 68 Both showed that patients receiving TIVA took longer to achieve eye opening in recovery; however, this did not translate to a significant delay in discharge from either recovery or hospital. Additionally, Raeder et al. 67 showed a significant reduction in PONV and pain in those who received TIVA, a finding further supported by Habib et al. 69 In this study, patients receiving a multimodal approach to PONV with anti-emetics and propofol were shown to have a significantly lower incidence of PONV and increased satisfaction with the management of their PONV compared with those receiving propofol alone or inhalational anaesthesia with anti-emetics.
Eight studies 7,70-76 evaluated the efficacy of different anti-emetic regimens in patients undergoing LC. Two placebo-controlled trials 7, 73 showed serotonergic antagonists such as ondansetron to be effective in reducing postoperative nausea 7 and vomiting. 7,73 Additionally, three studies 70-72 compared ondansetron with droperidol, metoclopramide or both and found no differences. In a randomized, placebo-controlled trial of 250 patients undergoing LC, Pandey et al. 74 assessed the efficacy of 600 mg gabapentin on PONV in the first postoperative 24 h. They found a statistically significant reduction in the incidence of PONV in the gabapentin group, but the severity of PONV was similar in both groups. Additionally, in patients given gabapentin, fentanyl requirements were reduced, which is consistent with the previously reported opioid-sparing effects of this treatment. 75 The efficacy of dixyrazine, a phenothiazine derivative, was studied by Glaser et al. 76 in a trial of 197 patients. The authors reported significantly more patients without PONV and fewer patients requiring rescue analgesia in the dixyrazine group.
Other anaesthetic techniques trialled have included epidural 77 and regional 78 anaesthesia. Only intercostal nerve blocks have been shown to reduce postoperative pain scores, although their clinical significance was debatable 78 (Level IB).
Postoperative interventions
One RCT 79 examined the effect of postoperative melatonin. Although the treatment group showed a reduction in sleep latency, no improvement in sleep quality, fatigue or generalized well-being emerged and therefore the authors concluded that this treatment could not be recommended (Level IIB).
In an RCT of 73 patients, Puolakka et al. 80 assessed the efficacy of parecoxib 40 mg vs. 80 mg placebo. All study drugs were administered at the end of anaesthesia. No significant differences between the groups emerged with respect to postoperative fentanyl consumption, incidence of PONV or use of anti-emetics. Despite the results of this well-powered study, it analysed outcomes at 20 h postoperatively and the authors acknowledged that this may not have been a long enough timeframe to study the analgesic efficacy of coxibs (Level IIB).
Discussion
Laparoscopic cholecystectomy remains one of the most commonly performed general surgical operations in both the acute and elective settings. Despite over two decades of experience, and the procedure's suitability to an ambulatory approach, it has not become widely accepted. Initial attempts at ambulatory cholecystectomy reported high rates of readmission, which may well have impaired its uptake, yet patients report high levels of satisfaction when the procedure is performed well.
6,7,18,81 As enhancedrecovery surgery becomes mainstream for major procedures, it has become clear that the most effective programmes are those which take a multimodal approach to treatment. 35, 82 Thus, the aim of this systematic review was to identify interventions that had the potential to reduce postoperative pain, fatigue and PONV following LC on the assumption that these symptoms are the main barriers to an ambulatory approach to LC. It is possible that other important factors may have been missed by this approach. However, this would seem unlikely in view of the available evidence for the causes of failed ambulatory cholecystectomy.
5-7 A total of 68 randomized trials met our study inclusion criteria and five interventions were identified as having evidence strong enough to support a Level IA recommendation.
Despite the large numbers of LC performed on a daily basis around the world, only 22 of the trials examined in this review enrolled over 100 patients. These were powered sufficiently for primary outcome measures, but placed secondary outcome measures at significant risk of type II errors; consequently, further trials are needed.
Pain following LC has been classified into three major types by Joris et al. 50 These include shoulder-tip pain, visceral pain (deep, dull pain that is hard to localize) and parietal pain (surface or wound-type pain). Joris et al. 50 demonstrated that visceral pain features in the first 24 h postoperatively, but is short-lived, whereas shoulder-tip pain is minor and features on postoperative day 2. These findings, however, contrast with those of Sarli et al., 44 who reported that shoulder-tip pain started at 3-6 h postoperatively, peaked at 12 h and rapidly improved thereafter. What is clear is that a single agent is unlikely to treat all three types of pain and a multimodal approach will be required.
Although almost all of the trials that assessed postoperative pain used VAS scores and/or postoperative analgesic requirements, the significant variations in technique, trial design, time at which data were measured and type of postoperative analgesia make it impossible to perform a meta-analysis and make intertrial comparisons difficult. Similar issues exist in terms of varia-tions in definitions of PONV, timing of measurement and use of postoperative rescue anti-emetics.
The other significant issue is that many trials showed statistically significant reductions in VAS pain scores which may not truly represent clinically significant reductions in pain. It is generally accepted that a clinically significant result for trials assessing pain should report a 2-point decrease (on a 10-point scale) or a 30% reduction in VAS scores. 83 Similarly, when pain is considered to be 'mild' to begin with (i.e. as reflected by a pain score of <4/10), it may be difficult to interpret any reduction as clinically meaningful. Future trials may need to overcome this by using more clinically relevant outcome measures, such as time to discharge or time to return to normal activities, as primary endpoints.
A further significant trend concerned the impact of the timing of the intervention on postoperative pain. It would seem that pre-emptive administration is important if the intervention is to be effective. For example, seven trials attempted to determine the effect of dexamethasone on PONV: in two trials, in which the treatment was administered 90 min prior to induction, significant reductions in postoperative pain scores were observed, but these effects were not seen when dexamethasone was given at induction. Similarly, preoperative analgesia, pre-incisional use of local anaesthetic, and administration of intraperitoneal local anaesthetic as soon as pneumoperitoneum is established and prior to performing cholecystectomy all appear to be important if the intervention is to be effective.
From the data assessed, it is clear that multiple interventions have been shown to be effective in improving outcomes following LC. Although multimodal interventional trials have been identified and many of these used a standardized approach, none included all of the interventions identified as useful. Many studies investigating PONV included the use of agents known to be emetogenic such as nitrous oxide, neostigmine and even volatile anaesthesia. 84 If the goal of the intervention is early discharge, it would make sense to use agents that are not associated with PONV.
It is therefore unclear which combination of interventions is necessary to achieve optimal rates of ambulatory LC. Given the high number of potential interventions, it would seem unlikely that an RCT could be designed to establish the optimal combination of interventions. Instead, it may be more practical and timely to design a clinical pathway or protocol which combines these evidence-based interventions and which measures predefined dichotomous outcomes, such as successful discharge within 6 h or 12 h, and time to return to work. Interventions could then be added or subtracted, their effects measured and analysed, and appropriate recommendations made. 
